Education
About Us
Working with TipRanks
Follow Us
MIRA Pharmaceuticals, Inc. (MIRA)
NASDAQ:MIRA
Total Valuation
MIRA Pharmaceuticals, Inc. has a market cap or net worth of ―. The enterprise value is ―.
Market Cap―
Enterprise Value―
Share Statistics
MIRA Pharmaceuticals, Inc. has 16,813,654 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding16,813,654
Owned by Insiders25.40%
Owned by Institutions0.10%
Financial Efficiency
MIRA Pharmaceuticals, Inc.’s return on equity (ROE) is -3.57 and return on invested capital (ROIC) is 0.00%.
Return on Equity (ROE)-3.57
Return on Assets (ROA)-2.69
Return on Invested Capital (ROIC)0.00%
Return on Capital Employed (ROCE)0.00
Revenue Per Employee0.00
Profits Per Employee-3.93M
Employee Count2
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of MIRA Pharmaceuticals, Inc. is -2.24. MIRA Pharmaceuticals, Inc.’s PEG ratio is 0.10.
PE Ratio-2.24
PS Ratio0.00
PB Ratio8.00
Price to Fair Value8.00
Price to FCF-3.17
Price to Operating Cash Flow-3.17
PEG Ratio0.10
Income Statement
In the last 12 months, MIRA Pharmaceuticals, Inc. had revenue of 0.00 and earned -7.85M in profits. Earnings per share was -0.51.
Revenue0.00
Gross Profit0.00
Operating Income0.00
Pretax Income-7.85M
Net Income-7.85M
EBITDA0.00
Earnings Per Share (EPS)-0.51
Cash Flow
In the last 12 months, operating cash flow was -5.89M and capital expenditures 0.00, giving a free cash flow of -5.89M billion.
Operating Cash Flow-5.89M
Free Cash Flow-5.89M
Free Cash Flow per Share-0.35
Dividends & Yields
MIRA Pharmaceuticals, Inc. pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-0.69
52-Week Price Change54.67%
50-Day Moving Average1.02
200-Day Moving Average1.35
Relative Strength Index (RSI)61.74
Average Volume (3m)2.05M
Important Dates
MIRA Pharmaceuticals, Inc. upcoming earnings date is ―, TBA Not Confirmed.
Last Earnings Date―
Next Earnings Date―
Ex-Dividend Date―
Financial Position
MIRA Pharmaceuticals, Inc. as a current ratio of 3.99, with Debt / Equity ratio of 0.00%
Current Ratio3.99
Quick Ratio3.99
Debt to Market Cap0.00
Net Debt to EBITDA0.00
Interest Coverage Ratio0.00
Taxes
In the past 12 months, MIRA Pharmaceuticals, Inc. has paid -7.85M in taxes.
Income Tax-7.85M
Effective Tax Rate0.00
Enterprise Valuation
MIRA Pharmaceuticals, Inc. EV to EBITDA ratio is 0.00, with an EV/FCF ratio of -2.66.
EV to Sales0.00
EV to EBITDA0.00
EV to Free Cash Flow-2.66
EV to Operating Cash Flow-2.66
Balance Sheet
MIRA Pharmaceuticals, Inc. has $4.14M in cash and marketable securities with $0.00 in debt, giving a net cash position of -$4.14M billion.
Cash & Marketable Securities$4.14M
Total Debt$0.00
Net Cash-$4.14M
Net Cash Per Share-$0.25
Tangible Book Value Per Share$0.14
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for MIRA Pharmaceuticals, Inc. is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―